Free Trial
OTCMKTS:PHGUF

Pharming Group (PHGUF) Stock Price, News & Analysis

Pharming Group logo
$1.00 0.00 (0.00%)
As of 05/23/2025

About Pharming Group Stock (OTCMKTS:PHGUF)

Key Stats

Today's Range
$1.00
$1.00
50-Day Range
$0.89
$1.00
52-Week Range
$0.75
$1.00
Volume
N/A
Average Volume
13,186 shs
Market Capitalization
$671.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Receive PHGUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

PHGUF Stock News Headlines

Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Pharming Group (PHAR) Receives a Buy from H.C. Wainwright
See More Headlines

PHGUF Stock Analysis - Frequently Asked Questions

Pharming Group's stock was trading at $0.9815 on January 1st, 2025. Since then, PHGUF stock has increased by 1.9% and is now trading at $1.00.
View the best growth stocks for 2025 here
.

Pharming Group (OTCMKTS:PHGUF) posted its quarterly earnings results on Thursday, March, 5th. The biotechnology company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.01. Pharming Group had a negative net margin of 6.09% and a negative trailing twelve-month return on equity of 7.65%.

Shares of PHGUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
3/05/2015
Today
5/25/2025
Next Earnings (Estimated)
7/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:PHGUF
Previous Symbol
OTC:PHGUF
CIK
N/A
Employees
382
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,550,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$245.32 million
Cash Flow
$0.01 per share
Price / Cash Flow
89.78
Book Value
$0.33 per share
Price / Book
3.03

Miscellaneous

Free Float
N/A
Market Cap
$671.07 million
Optionable
Not Optionable
Beta
0.51

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:PHGUF) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners